Dr. Steven D. Chang is a Professor and Vice Chairman of Strategic Development and Innovation in the Department of Neurosurgery at Stanford University. He holds the Robert C. and Jeannette Powell Professorship in the Neurosciences. His clinical and research work focuses on brain tumors and cerebrovascular disease. After earning his medical degree and completing his residency at Stanford, Dr. Chang joined the faculty in 2000 and became a full professor in 2008. He is renowned for his expertise in microsurgery and radiosurgery for brain, spine, and skull base tumors. He co-directs the Surgical Neuro-Oncology Program and the Stanford Cyberknife Radiosurgery Program. Dr. Chang also specializes in treating arteriovenous malformations, cavernous malformations, and intracranial aneurysms. His research includes clinical outcomes for radiosurgery of brain and spine tumors and genetic analysis of arteriovenous malformation patients. He directs the Stanford Neurogenetics Oncology Program and the Stanford Neuromolecular Innovations Program. Dr. Chang has authored over 300 peer-reviewed publications and book chapters.

Dr. David Park, M.D., P.D., is a Clinical Assistant Professor at Stanford University specializing in neurosurgical oncology and skull base surgery. He earned his medical degree from the Catholic University of Korea and completed his residency at Seoul St. Mary's Hospital. Dr. Park has extensive international experience, including fellowships at the National Neuroscience Institute in Singapore and Massachusetts General Hospital, Harvard Medical School. In the U.S., he completed fellowships in neurosurgical oncology and radiosurgery at North Shore University Hospital and the Cleveland Clinic. His expertise includes minimally invasive techniques like Laser Interstitial Thermal Therapy (LITT) and Gamma Knife Stereotactic Radiosurgery (SRS). At Stanford, Dr. Park collaborates with Dr. Steven D. Chang, focusing on neurosurgical oncology and CyberKnife® SRS. His research interests include fluorescence-guided surgery and the role of fatty acids in glioblastoma.

Dr. Gu is an Associate Professor and Director of Translational Research in the Radiation Oncology Department at Stanford University. Her research focuses on AI in medicine, medical imaging, and treatment planning. She has significantly contributed to translating software platforms into clinical use. Dr. Gu has authored over 100 peer-reviewed publications, holds numerous patents, and is involved in NIH and corporate grants. She also serves on the editorial boards of several medical physics and imaging journals.

Dr. Fred Chiu-Lai Lam is a Clinical Instructor in Neurosurgery at Stanford Health Care. A Canadian board-certified neurosurgeon with a Ph.D. in neuroscience, he completed his fellowship at Harvard Medical School, specializing in brain and spine tumors. He also trained at the University of Alberta and the University of British Columbia. Dr. Lam focuses on fluorescence image-guided neurosurgery and stereotactic radiosurgery to improve brain tumor outcomes. At Stanford, he combines clinical practice with academic research to advance neurosurgical techniques and patient care.

Dr. Marc Levivier, M.D., Ph.D., is a Full Professor at the University of Lausanne and Chairman of Neurosurgery at Lausanne University Hospital (CHUV). Trained at the Free University of Brussels, he specializes in stereotactic and functional neurosurgery, and Gamma Knife radiosurgery. Since 2007, he has co-directed the Centre Universitaire Romand de Neurochirurgie and led the Gamma Knife Center at CHUV. Dr. Levivier has over 350 scientific publications focusing on image-guided and minimally invasive neurosurgery.

Dr. Alexander Muacevic is the Medical Director of the European Cyberknife® Center in Munich and a faculty member at the University of Munich Hospitals. A board-certified neurosurgeon and radiosurgeon, he specializes in full-body radiosurgery using advanced robotic technology. Dr. Muacevic has published over 100 scientific works and is president of the International Radiosurgery Society. He also co-founded and serves as Co-Editor-in-Chief of the Cureus Journal of Medical Science.

Dr. Pantaleo Romanelli is the Chief of Neurosurgery & Neuromodulation and Co-Director of Stereotactic Radiosurgery at the Renaissance Institute. Trained in Italy and the U.S., he has held positions at Stanford and Neuromed Pozzilli. Dr. Romanelli specializes in advanced radiosurgical techniques for neurological conditions, focusing on movement disorders, epilepsy, and chronic pain. He has received numerous awards, authored many scientific publications, and is dedicated to innovative, patient-centered care.

Dr. Michael Schulder, M.D., is the Director of the Brain Tumor Center at Northwell Neuroscience Institute and Vice-Chairman of Neurosurgery at North Shore University Hospital. He is also a Professor of Neurosurgery at the Zucker School of Medicine at Hofstra/Northwell and co-directs the Northwell Health Center for Stereotactic Radiosurgery. Dr. Schulder specializes in stereotactic neurooncology, has over 100 peer-reviewed publications, and focuses on using image guidance to improve brain surgery outcomes.

Dr. Scott G. Soltys, M.D., is a Professor of Radiation Oncology and Neurosurgery at Stanford University. He co-directs the Stanford Radiosurgery Program and directs the Residency Program. Specializing in stereotactic radiosurgery for CNS tumors, Dr. Soltys earned his medical degree from the University of Michigan and completed his residency at Stanford. He has received numerous awards and authored over 300 peer-reviewed publications. His research focuses on clinical outcomes for radiosurgery and genetic analysis of arteriovenous malformations.

Dr. John Suh, M.D., is the Chairman of Radiation Oncology and Associate Director of the Gamma Knife Center at Cleveland Clinic's Brain Tumor and Neuro-Oncology Center. He earned his degrees from the University of Miami and completed his training at Cleveland Clinic, joining the staff in 1995. Dr. Suh is a Board Examiner for the American Board of Radiology and a reviewer for various medical journals. His research focuses on brain tumors, Gamma Knife radiosurgery, and innovative radiation modalities.